Relypsa
Redwood City
About Relypsa
Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $669.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (May 2016)
- Ticker: nasdaq:RLYP
- Website: relypsa.com
- Phone: +1 650 421 9500
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/relypsa-104237 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.